Modular pharmacology: Deciphering the interacting structural organization of the targeted networks

Drug Discovery Today

Volumn 18, Issue 11-12, 2013, Pages 560-566

  Wang, Zhong ^a   Wang, Yong Yan ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BEVACIZUMAB; CANDESARTAN HEXETIL; DICLOFENAC; ERLOTINIB; INDIRUBIN; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; PARACETAMOL; RAMIPRIL; RETINOIC ACID; SORAFENIB; SUNITINIB; TANSHINONE IIA; TETRAARSENIC TETRASULFIDE; UNCLASSIFIED DRUG;

DISEASES; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TARGETING; GENE EXPRESSION; GENE PRODUCT; GENOME; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; MEDICAL RESEARCH; MODULAR PHARMACOLOGY; PHARMACOLOGY; REVIEW; TRANSCRIPTION REGULATION;

DRUG DISCOVERY; GENE REGULATORY NETWORKS; PHARMACOLOGY; SYSTEMS BIOLOGY;

EID: 84878853330     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.01.009     Document Type: Review

References (58)

1. Q.W. Fan A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma Cancer Cell 9 2006 341 349
2. D. Kim Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma Expert Opin. Drug Metab. Toxicol. 5 2009 933 940
3. P.P. Karjalainen Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting Eur. Heart J. 28 2007 726 732
4. S. Anand Oral anticoagulant and antiplatelet therapy and peripheral arterial disease N. Engl. J. Med. 357 2007 217 227
5. K.T. Flaherty Chemotherapy and targeted therapy combinations in advanced melanoma Clin. Cancer Res. 12 2006 2366s 2370s
6. A. Wang Modular pharmacology: the next paradigm in drug discovery Expert Opin. Drug Discov. 7 2012 667 677
7. S.E. Calvano A network-based analysis of systemic inflammation in humans Nature 437 2005 1032 1037
8. B. Lehner Modelling genotype-phenotype relationships and human disease with genetic interaction networks J. Exp. Biol. 210 2007 1559 1566
9. S.M. Kornblau Functional proteomic profiling of AML predicts response and survival Blood 113 2009 154 164
10. P. Csermely The efficiency of multi-target drugs: the network approach might help drug design Trends Pharmacol. Sci. 26 2005 178 182
11. S.L. Kinnings The Mycobacterium tuberculosis drugome and its polypharmacological implications PLoS Comput. Biol. 6 2010 e1000976
12. J.C. Nacher, and J.M. Schwartz Modularity in protein complex and drug interactions reveals new polypharmacological properties PLoS ONE 7 2012 e30028
13. K. Sameith Functional modules integrating essential cellular functions are predictive of the response of leukaemia cells to DNA damage Bioinformatics 24 2008 2602 2607
14. D.H. Geschwind, and G. Konopka Neuroscience in the era of functional genomics and systems biology Nature 461 2009 908 915
15. M.J.A. Walker Functional pharmacology: the drug discovery bottleneck? Drug Discov. Today. Targets 3 2004 208 215
16. J. Jeon Network clustering revealed the systemic alterations of mitochondrial protein expression PLoS Comput. Biol. 7 2011 e1002093
17. A.J. Enright An efficient algorithm for large-scale detection of protein families Nucleic Acids Res. 30 2002 1575 1584
18. G.D. Bader, and C.W. Hogue An automated method for finding molecular complexes in large protein interaction networks BMC Bioinform. 4 2003 2
19. I.A. Maraziotis An in silico method for detecting overlapping functional modules from composite biological networks BMC Syst. Biol. 2 2008 93
20. K. Rhrissorrakrai, and K.C. Gunsalus MINE: module identification in networks BMC Bioinform. 12 2011 192
21. E. Segal From signatures to models: understanding cancer using microarrays Nat. Genet. 37 2005 S38 S45
22. L. Yu Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling Physiol. Genomics 37 2009 199 210
23. J.C. Liao Network component analysis: reconstruction of regulatory signals in biological systems Proc. Natl. Acad. Sci. U. S. A. 100 2003 15522 15527
24. S. Ben-Tabou de-Leon, and E.H. Davidson Deciphering the underlying mechanism of specification and differentiation: the sea urchin gene regulatory network Sci. STKE 361 2006 pe47
25. B.B. Tuch Evolution of eukaryotic transcription circuits Science 319 2008 1797 1799
26. J. Stelling Understandable complexity Sci. STKE 376 2007 pe9
27. H.D. Kim Transcriptional regulatory circuits: predicting numbers from alphabets Science 325 2009 429 432
28. C.Y. Cheng, and Y.J. Hu Extracting the abstraction pyramid from complex networks BMC Bioinform. 11 2010 411
29. M. Mate Szalay-Beko ModuLand plug-in for Cytoscape: determination of hierarchical layers of overlapping modules and community centrality Bioinformatics 28 2012 2202 2204
30. E. Mones Hierarchy measure for complex networks PLoS ONE 7 2012 e33799
31. W.C. Hwang Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery Clin. Pharmacol. Ther. 84 2008 563 572
32. Y. Shen Blueprint for antimicrobial hit discovery targeting metabolic networks Proc. Natl. Acad. Sci. U. S. A. 107 2010 1082 1087
33. M.A. Rogawski Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents-toward an understanding of their favorable tolerability Amino Acids 19 2000 133 149
34. M.L. Keiser Predicting new molecular targets for known drugs Nature 462 2009 175 181
35. J.S. Bader New connections, new components, real dynamics Sci. Signal. 2 2009 pe48
36. E.E. Schadt, and P.Y. Lum Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes J. Lipid Res. 47 2006 2601 2613
37. O. Resendis-Antonio Functional modules, structural topology, and optimal activity in metabolic networks PLoS Comput. Biol. 8 2012 E1002720
38. L. De Laporte Design of modular non-viral gene therapy vectors Biomaterials 27 2006 947 954
39. G. An Introduction of an agent-based multi-scale modular architecture for dynamic knowledge representation of acute inflammation Theor. Biol. Med. Model. 5 2008 11
40. A. Sina Computational identification of key biological modules and transcription factors in acute lung injury Am. J. Respir. Crit. Care Med. 173 2006 653 658
41. A. Arenas Optimal map of the modular structure of complex networks New J. Phys. 12 2010 053009
42. C.M. Jeffries Human cardiac myosin binding protein C: structural flexibility within an extended modular architecture J. Mol. Biol. 414 2006 735 748
43. K. Yang Finding multiple target optimal intervention in disease-related molecular network Mol. Syst. Biol. 4 2008 1 13
44. M.K. Hellerstein Exploiting complexity and the robustness of network architecture for drug discovery J. Pharmacol. Exp. Ther. 325 2008 1 9
45. D. Rognan Chemogenomic approaches to rational drug design. Bioinformatics of the Drug, CNRS UMR 7175-LC1, Illkirch, France Br. J. Pharmacol. 152 2007 38 52
46. J. Tegner Reverse engineering gene networks: integrating genetic perturbations with dynamical modeling Proc. Natl. Acad. Sci. U. S. A. 100 2003 5944 5949
47. J. van der Greef, and R.N. McBurney Innovation: rescuing drug discovery: in vivo systems pathology and systems pharmacology Nat. Rev. Drug Discov. 4 2005 961 967
48. L.J. Gershell, and J.H. Atkins A brief history of novel drug discovery technologies Nat. Rev. Drug Discov. 2 2003 321 327
49. B. Apsel Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases Nat. Chem. Biol. 4 2008 691 699
50. F.J. Doyle, and J. Stelling Systems interface biology J. R. Soc. Interface 3 2006 603 616
51. E. Szczurek Elucidating regulatory mechanisms downstream of a signaling pathway using informative experiments Mol. Syst. Biol. 5 2009 287 296
52. S.R. Banerjee A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA) Oncotarget 2 2011 1244 1253
53. 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia Proc. Natl. Acad. Sci. U. S. A. 101 2004 5328 5335
54. P. Lunghi Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways Blood 112 2008 2450 2462
55. J.A. Sosman Opportunities and obstacles to combination targeted therapy in renal cell cancer Clin. Cancer Res. 13 2007 764s 769s
56. L. Wang Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia Proc. Natl. Acad. Sci. U. S. A. 105 2008 4826 4831
57. M.J. Rokoss, and K.K. Teo Ramipril in the treatment of vascular diseases Expert Opin. Pharmacother. 6 2005 1911 1919
58. M. Ouellet, and M.D. Percival Mechanism of acetaminophen inhibition of cyclooxygenase isoforms Arch. Biochem. Biophys. 387 2001 273 280